Form4insider filings, from the source

SEC Form 4 · accession 0001193805-15-000295

Invitae Corp · NVTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
DEERFIELD MANAGEMENT CO
10% Owner · Other
Deerfield Mgmt L.P.
10% Owner · Other
James E Flynn
10% Owner · Other
Period of report
Feb 18, 2015
Accepted (ET)
Feb 19, 2015 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501134

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Feb 18, 2015C166,666—A166,666IThrough Deerfield Special Situations Fund, L.P.
Common StockF2,F3Feb 18, 2015P87,500$16.00A254,166IThrough Deerfield Special Situations Fund, L.P.
Common StockF2,F3Feb 18, 2015P39,112$16.00A39,112IThrough Deerfield Partners, L.P.
Common StockF2,F3Feb 18, 2015P48,388$16.00A48,388IThrough Deerfield International Master Fund, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series F Preferred StockF1,F2,F3—Feb 18, 2015C1,000,000D——Common Stock166,6660I

Explanation of responses

Remarks

David Clark, signing as Attorney-in-Fact: Power of Attorney, incorporated by reference to Exhibit 24 to a Form 3 with regard to Avalanche Biotechnologies, Inc. filed with the Securities and Exchange Commission on July 30, 2014 by Deerfield Mgmt L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P., Deerfield Private Design Fund III, L.P. and James E. Flynn.